基于CiteSpace软件分析医院药品精细化管理的现状<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2025.02.001

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1456 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To analyze the current status of refined drug management in hospitals based on CiteSpace software analysis.【Methods】CiteSpace software was used to visually analyze relevant domestic literature, explore the trends and hotspots of hospital drug refinement management under the background of the new medical reform. The five aspects: authors, research institutions, high-frequency keywords, keyword clustering, and keyword emergence diagram were analyzed.【Results】Refined management of drugs improved the quality and safety of drugs, reduce medical costs, and improve the efficiency and quality of medical services. At the same time, it also enhanced patients' trust and satisfaction with medical services and promoted the harmonious development of doctor-patient relationships.【Conclusion】Through literature analysis of the past 14 years in the field of refined drug management in China, drug management has evolved from an initial focus on economic benefits, cost accounting, and drug procurement strategies, to a gradual focus on outpatient pharmacy management and drug inventory management, as well as a later focus on antimicrobial drug management, financial management, and overall hospital operation at multiple levels of research and hot topics. At the same time, it is predicted that in the future, refined drug management will pay more attention to controlling medical expenses, optimizing hospitalization expenses, conducting personalized treatment strategies based on disease diagnosis, and improving work efficiency.

Key words： Hospital Administration Drug and Narcotic Control Software

Received: 11 September 2024

PACS:

R954

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Zhanwu
	LI Ruike
	LIU Wei
	et al

Cite this article:

LI Zhanwu,LI Ruike,LIU Wei, et al. Research on the Current Situation of Refine Drug Management in Hospitals Based on CiteSpace Analysis[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(2): 177-180.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.02.001 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I2/177

[1] FEDERICO P, HEIMERL F, KOCH S, et al. A survey on visual approaches for analyzing scientific literature and patents[J].IEEE Trans Vis Comput Graph,2017,23(9): 2179-2198.
[2] 刘雪莉,张红. 基于CiteSpace的相依关系研究热点可视化分析[J].中西医结合护理,2023, 9(10): 82-88.
[3] 陈超美,陈悦,侯剑华,等. CiteSpace Ⅱ:科学文献中新趋势与新动态的识别与可视化[J].情报学报, 2009, 28(3): 401-421.
[4] CHEN C M, HU Z G, LIU S B, et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace[J].Expert Opin Biol Ther,2012, 12(5): 593-608.
[5] CHEN C M. CiteSpace Ⅱ: Detecting and visualizing emerging trends and transient patterns in scientific literature[J].J Am Soc Informat Sci Technol,2006, 57(3): 359-377.
[6] 周雨佳,史亦丽,朱珠,等. 我院病区注射用麻醉药品使用剩余量初探[J].中国药师, 2015, 18(11): 1947-1950.
[7] 周雨佳,史亦丽,朱珠,等. 我院病区及手术室注射用麻醉药品处方书写规范性分析[J].中国药师, 2016, 19(2): 392-395.
[8] 黄茜,陈常凤,史亦丽. 6000张门诊处方点评与分析[J].中国医院用药评价与分析, 2015, 15(8): 1103-1106.
[9] 周雨佳,史亦丽,朱珠,等. 我院手术室注射用麻醉药品使用剩余量初探[J].中国药师,2015, 18(10): 1763-1766.
[10] 伍渊麟,向贵圆,何霜霜,等. 基于结构变动度分析法的呼吸与危重症医学科疾病诊断相关分组超支病例用药管理实践[J].中国药业, 2023, 32(5): 6-11.
[11] 伍渊麟,陈世耕,鲜秋婉,等. DRG背景下临床药师参与消化内科药事精细化管理的实践[J].中国药房, 2022, 33(17): 2157-2161.
[12] 伍渊麟,刘耀,甘岚澜,等. DRG支付方式下EB19组胸部大手术患者住院费用的影响因素研究[J].重庆医学, 2023, 52(23): 3665-3668.
[13] 冯峰. 基于医保收费政策的住院药学服务信息管理模块开发[J].中国现代应用药学,2023, 40(17): 2360-2365.
[14] 宋妍. 浅析高危药品在门诊药房管理中存在的不足和解决措施[J].中国卫生产业,2016, 13(12): 176-178.
[15] 吕静静. 精细化管理视角下的公立医院成本管理策略研究[J].财会学习, 2023, 379(26): 115-117.
[16] 柴煜莹,孙怡,唐婕. 医院新型供应链SPD管理模式在中心药房药品管理中的应用[J].中南药学, 2023, 21(8): 2215-2218.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(2): 319-321.